Page last updated: 2024-11-12

11-hydroxy-n-(n-propyl)noraporphine hydrochloride, (r)-isomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID10333842
CHEMBL ID27559
SCHEMBL ID1203699
MeSH IDM0310157

Synonyms (7)

Synonym
(r)-oh-n-propylnoraporphine
CHEMBL27559 ,
bdbm84636
npa-11-oh-r,(+)
SCHEMBL1203699
114033-65-7
PD129363

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (13)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tyrosine 3-monooxygenaseHomo sapiens (human)IC50 (µMol)42.00000.30000.51000.7200AID313108
5-hydroxytryptamine receptor 1AHomo sapiens (human)Ki0.04500.00010.532610.0000AID460125
D(2) dopamine receptorHomo sapiens (human)Ki3.37560.00000.651810.0000AID387704; AID460127; AID64306
DRattus norvegicus (Norway rat)IC50 (µMol)0.36800.00030.50267.7625AID45982; AID45983
DRattus norvegicus (Norway rat)Ki0.61790.00010.610010.0000AID313111; AID317240; AID340034; AID411966; AID61367; AID61514; AID63012
D(3) dopamine receptorRattus norvegicus (Norway rat)IC50 (µMol)0.36800.00030.39075.4000AID45982; AID45983
D(3) dopamine receptorRattus norvegicus (Norway rat)Ki0.00400.00010.25675.8000AID63012
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)Ki5.02000.00010.739610.0000AID313114; AID387701
D(1A) dopamine receptorHomo sapiens (human)Ki4.78170.00010.836310.0000AID387703; AID460126; AID569899
D(1B) dopamine receptorRattus norvegicus (Norway rat)IC50 (µMol)0.36800.00030.35635.4000AID45982; AID45983
D(1B) dopamine receptorRattus norvegicus (Norway rat)Ki0.00400.00020.24622.0000AID63012
5-hydroxytryptamine receptor 2AHomo sapiens (human)Ki0.11400.00000.385510.0000AID387702
D(4) dopamine receptorRattus norvegicus (Norway rat)IC50 (µMol)0.36800.00030.38715.4000AID45982; AID45983
D(4) dopamine receptorRattus norvegicus (Norway rat)Ki0.00400.00020.18872.0000AID63012
Histamine H1 receptorCavia porcellus (domestic guinea pig)Ki0.11400.00261.783210.0000AID387702
D(3) dopamine receptorHomo sapiens (human)Ki0.85060.00000.602010.0000AID569898; AID569902
D(2) dopamine receptorRattus norvegicus (Norway rat)IC50 (µMol)0.36800.00010.54948.4000AID45982; AID45983
D(2) dopamine receptorRattus norvegicus (Norway rat)Ki0.19200.00000.437510.0000AID313112; AID317241; AID340035; AID411967; AID569896; AID569897; AID63012; AID64953
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (219)

Processvia Protein(s)Taxonomy
response to hypoxiaTyrosine 3-monooxygenaseHomo sapiens (human)
synaptic transmission, dopaminergicTyrosine 3-monooxygenaseHomo sapiens (human)
response to amphetamineTyrosine 3-monooxygenaseHomo sapiens (human)
heart morphogenesisTyrosine 3-monooxygenaseHomo sapiens (human)
dopamine biosynthetic process from tyrosineTyrosine 3-monooxygenaseHomo sapiens (human)
fatty acid metabolic processTyrosine 3-monooxygenaseHomo sapiens (human)
sphingolipid metabolic processTyrosine 3-monooxygenaseHomo sapiens (human)
heart developmentTyrosine 3-monooxygenaseHomo sapiens (human)
visual perceptionTyrosine 3-monooxygenaseHomo sapiens (human)
learningTyrosine 3-monooxygenaseHomo sapiens (human)
memoryTyrosine 3-monooxygenaseHomo sapiens (human)
mating behaviorTyrosine 3-monooxygenaseHomo sapiens (human)
locomotory behaviorTyrosine 3-monooxygenaseHomo sapiens (human)
regulation of heart contractionTyrosine 3-monooxygenaseHomo sapiens (human)
response to light stimulusTyrosine 3-monooxygenaseHomo sapiens (human)
response to herbicideTyrosine 3-monooxygenaseHomo sapiens (human)
response to salt stressTyrosine 3-monooxygenaseHomo sapiens (human)
anatomical structure morphogenesisTyrosine 3-monooxygenaseHomo sapiens (human)
animal organ morphogenesisTyrosine 3-monooxygenaseHomo sapiens (human)
response to zinc ionTyrosine 3-monooxygenaseHomo sapiens (human)
response to activityTyrosine 3-monooxygenaseHomo sapiens (human)
aminergic neurotransmitter loading into synaptic vesicleTyrosine 3-monooxygenaseHomo sapiens (human)
glycoside metabolic processTyrosine 3-monooxygenaseHomo sapiens (human)
phthalate metabolic processTyrosine 3-monooxygenaseHomo sapiens (human)
cerebral cortex developmentTyrosine 3-monooxygenaseHomo sapiens (human)
response to nutrient levelsTyrosine 3-monooxygenaseHomo sapiens (human)
response to estradiolTyrosine 3-monooxygenaseHomo sapiens (human)
response to lipopolysaccharideTyrosine 3-monooxygenaseHomo sapiens (human)
isoquinoline alkaloid metabolic processTyrosine 3-monooxygenaseHomo sapiens (human)
social behaviorTyrosine 3-monooxygenaseHomo sapiens (human)
response to isolation stressTyrosine 3-monooxygenaseHomo sapiens (human)
response to immobilization stressTyrosine 3-monooxygenaseHomo sapiens (human)
terpene metabolic processTyrosine 3-monooxygenaseHomo sapiens (human)
dopamine biosynthetic processTyrosine 3-monooxygenaseHomo sapiens (human)
epinephrine biosynthetic processTyrosine 3-monooxygenaseHomo sapiens (human)
norepinephrine biosynthetic processTyrosine 3-monooxygenaseHomo sapiens (human)
eye photoreceptor cell developmentTyrosine 3-monooxygenaseHomo sapiens (human)
circadian sleep/wake cycleTyrosine 3-monooxygenaseHomo sapiens (human)
eating behaviorTyrosine 3-monooxygenaseHomo sapiens (human)
response to peptide hormoneTyrosine 3-monooxygenaseHomo sapiens (human)
pigmentationTyrosine 3-monooxygenaseHomo sapiens (human)
response to ethanolTyrosine 3-monooxygenaseHomo sapiens (human)
response to etherTyrosine 3-monooxygenaseHomo sapiens (human)
response to pyrethroidTyrosine 3-monooxygenaseHomo sapiens (human)
embryonic camera-type eye morphogenesisTyrosine 3-monooxygenaseHomo sapiens (human)
response to corticosteroneTyrosine 3-monooxygenaseHomo sapiens (human)
response to electrical stimulusTyrosine 3-monooxygenaseHomo sapiens (human)
phytoalexin metabolic processTyrosine 3-monooxygenaseHomo sapiens (human)
cellular response to manganese ionTyrosine 3-monooxygenaseHomo sapiens (human)
cellular response to alkaloidTyrosine 3-monooxygenaseHomo sapiens (human)
cellular response to nicotineTyrosine 3-monooxygenaseHomo sapiens (human)
cellular response to glucose stimulusTyrosine 3-monooxygenaseHomo sapiens (human)
cellular response to growth factor stimulusTyrosine 3-monooxygenaseHomo sapiens (human)
cellular response to xenobiotic stimulusTyrosine 3-monooxygenaseHomo sapiens (human)
hyaloid vascular plexus regressionTyrosine 3-monooxygenaseHomo sapiens (human)
behavioral fear response5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
adenylate cyclase-inhibiting serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
gamma-aminobutyric acid signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
positive regulation of cell population proliferation5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of serotonin secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of vasoconstriction5-hydroxytryptamine receptor 1AHomo sapiens (human)
exploration behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of dopamine metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of hormone secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
chemical synaptic transmission5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger5-hydroxytryptamine receptor 1AHomo sapiens (human)
phospholipase C-activating dopamine receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
temperature homeostasisD(2) dopamine receptorHomo sapiens (human)
response to hypoxiaD(2) dopamine receptorHomo sapiens (human)
negative regulation of protein phosphorylationD(2) dopamine receptorHomo sapiens (human)
response to amphetamineD(2) dopamine receptorHomo sapiens (human)
nervous system process involved in regulation of systemic arterial blood pressureD(2) dopamine receptorHomo sapiens (human)
regulation of heart rateD(2) dopamine receptorHomo sapiens (human)
regulation of sodium ion transportD(2) dopamine receptorHomo sapiens (human)
G protein-coupled receptor internalizationD(2) dopamine receptorHomo sapiens (human)
positive regulation of neuroblast proliferationD(2) dopamine receptorHomo sapiens (human)
positive regulation of receptor internalizationD(2) dopamine receptorHomo sapiens (human)
autophagyD(2) dopamine receptorHomo sapiens (human)
adenylate cyclase-inhibiting dopamine receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
neuron-neuron synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
neuroblast proliferationD(2) dopamine receptorHomo sapiens (human)
axonogenesisD(2) dopamine receptorHomo sapiens (human)
synapse assemblyD(2) dopamine receptorHomo sapiens (human)
sensory perception of smellD(2) dopamine receptorHomo sapiens (human)
long-term memoryD(2) dopamine receptorHomo sapiens (human)
grooming behaviorD(2) dopamine receptorHomo sapiens (human)
locomotory behaviorD(2) dopamine receptorHomo sapiens (human)
adult walking behaviorD(2) dopamine receptorHomo sapiens (human)
protein localizationD(2) dopamine receptorHomo sapiens (human)
negative regulation of cell population proliferationD(2) dopamine receptorHomo sapiens (human)
associative learningD(2) dopamine receptorHomo sapiens (human)
visual learningD(2) dopamine receptorHomo sapiens (human)
response to xenobiotic stimulusD(2) dopamine receptorHomo sapiens (human)
response to light stimulusD(2) dopamine receptorHomo sapiens (human)
response to toxic substanceD(2) dopamine receptorHomo sapiens (human)
response to iron ionD(2) dopamine receptorHomo sapiens (human)
response to inactivityD(2) dopamine receptorHomo sapiens (human)
Wnt signaling pathwayD(2) dopamine receptorHomo sapiens (human)
striatum developmentD(2) dopamine receptorHomo sapiens (human)
orbitofrontal cortex developmentD(2) dopamine receptorHomo sapiens (human)
cerebral cortex GABAergic interneuron migrationD(2) dopamine receptorHomo sapiens (human)
adenohypophysis developmentD(2) dopamine receptorHomo sapiens (human)
negative regulation of cell migrationD(2) dopamine receptorHomo sapiens (human)
peristalsisD(2) dopamine receptorHomo sapiens (human)
auditory behaviorD(2) dopamine receptorHomo sapiens (human)
regulation of synaptic transmission, GABAergicD(2) dopamine receptorHomo sapiens (human)
positive regulation of cytokinesisD(2) dopamine receptorHomo sapiens (human)
circadian regulation of gene expressionD(2) dopamine receptorHomo sapiens (human)
negative regulation of dopamine secretionD(2) dopamine receptorHomo sapiens (human)
response to histamineD(2) dopamine receptorHomo sapiens (human)
response to nicotineD(2) dopamine receptorHomo sapiens (human)
positive regulation of urine volumeD(2) dopamine receptorHomo sapiens (human)
positive regulation of renal sodium excretionD(2) dopamine receptorHomo sapiens (human)
positive regulation of multicellular organism growthD(2) dopamine receptorHomo sapiens (human)
response to cocaineD(2) dopamine receptorHomo sapiens (human)
negative regulation of circadian sleep/wake cycle, sleepD(2) dopamine receptorHomo sapiens (human)
dopamine metabolic processD(2) dopamine receptorHomo sapiens (human)
drinking behaviorD(2) dopamine receptorHomo sapiens (human)
regulation of potassium ion transportD(2) dopamine receptorHomo sapiens (human)
response to morphineD(2) dopamine receptorHomo sapiens (human)
pigmentationD(2) dopamine receptorHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionD(2) dopamine receptorHomo sapiens (human)
positive regulation of G protein-coupled receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
negative regulation of blood pressureD(2) dopamine receptorHomo sapiens (human)
negative regulation of innate immune responseD(2) dopamine receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IID(2) dopamine receptorHomo sapiens (human)
negative regulation of insulin secretionD(2) dopamine receptorHomo sapiens (human)
acid secretionD(2) dopamine receptorHomo sapiens (human)
behavioral response to cocaineD(2) dopamine receptorHomo sapiens (human)
behavioral response to ethanolD(2) dopamine receptorHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityD(2) dopamine receptorHomo sapiens (human)
response to axon injuryD(2) dopamine receptorHomo sapiens (human)
branching morphogenesis of a nerveD(2) dopamine receptorHomo sapiens (human)
arachidonic acid secretionD(2) dopamine receptorHomo sapiens (human)
epithelial cell proliferationD(2) dopamine receptorHomo sapiens (human)
negative regulation of epithelial cell proliferationD(2) dopamine receptorHomo sapiens (human)
negative regulation of protein secretionD(2) dopamine receptorHomo sapiens (human)
release of sequestered calcium ion into cytosolD(2) dopamine receptorHomo sapiens (human)
dopamine uptake involved in synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
regulation of dopamine uptake involved in synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
positive regulation of dopamine uptake involved in synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
regulation of synapse structural plasticityD(2) dopamine receptorHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionD(2) dopamine receptorHomo sapiens (human)
negative regulation of synaptic transmission, glutamatergicD(2) dopamine receptorHomo sapiens (human)
excitatory postsynaptic potentialD(2) dopamine receptorHomo sapiens (human)
positive regulation of growth hormone secretionD(2) dopamine receptorHomo sapiens (human)
prepulse inhibitionD(2) dopamine receptorHomo sapiens (human)
negative regulation of dopamine receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeD(2) dopamine receptorHomo sapiens (human)
regulation of locomotion involved in locomotory behaviorD(2) dopamine receptorHomo sapiens (human)
postsynaptic modulation of chemical synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
negative regulation of cellular response to hypoxiaD(2) dopamine receptorHomo sapiens (human)
positive regulation of glial cell-derived neurotrophic factor productionD(2) dopamine receptorHomo sapiens (human)
positive regulation of long-term synaptic potentiationD(2) dopamine receptorHomo sapiens (human)
hyaloid vascular plexus regressionD(2) dopamine receptorHomo sapiens (human)
negative regulation of neuron migrationD(2) dopamine receptorHomo sapiens (human)
negative regulation of cytosolic calcium ion concentrationD(2) dopamine receptorHomo sapiens (human)
regulation of dopamine secretionD(2) dopamine receptorHomo sapiens (human)
negative regulation of adenylate cyclase activityD(2) dopamine receptorHomo sapiens (human)
phospholipase C-activating dopamine receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
negative regulation of voltage-gated calcium channel activityD(2) dopamine receptorHomo sapiens (human)
positive regulation of MAPK cascadeD(2) dopamine receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
temperature homeostasisD(1A) dopamine receptorHomo sapiens (human)
conditioned taste aversionD(1A) dopamine receptorHomo sapiens (human)
behavioral fear responseD(1A) dopamine receptorHomo sapiens (human)
regulation of protein phosphorylationD(1A) dopamine receptorHomo sapiens (human)
synaptic transmission, dopaminergicD(1A) dopamine receptorHomo sapiens (human)
response to amphetamineD(1A) dopamine receptorHomo sapiens (human)
protein import into nucleusD(1A) dopamine receptorHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerD(1A) dopamine receptorHomo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayD(1A) dopamine receptorHomo sapiens (human)
activation of adenylate cyclase activityD(1A) dopamine receptorHomo sapiens (human)
adenylate cyclase-activating dopamine receptor signaling pathwayD(1A) dopamine receptorHomo sapiens (human)
synapse assemblyD(1A) dopamine receptorHomo sapiens (human)
memoryD(1A) dopamine receptorHomo sapiens (human)
mating behaviorD(1A) dopamine receptorHomo sapiens (human)
grooming behaviorD(1A) dopamine receptorHomo sapiens (human)
adult walking behaviorD(1A) dopamine receptorHomo sapiens (human)
visual learningD(1A) dopamine receptorHomo sapiens (human)
response to xenobiotic stimulusD(1A) dopamine receptorHomo sapiens (human)
astrocyte developmentD(1A) dopamine receptorHomo sapiens (human)
dopamine transportD(1A) dopamine receptorHomo sapiens (human)
transmission of nerve impulseD(1A) dopamine receptorHomo sapiens (human)
neuronal action potentialD(1A) dopamine receptorHomo sapiens (human)
dentate gyrus developmentD(1A) dopamine receptorHomo sapiens (human)
striatum developmentD(1A) dopamine receptorHomo sapiens (human)
cerebral cortex GABAergic interneuron migrationD(1A) dopamine receptorHomo sapiens (human)
positive regulation of cell migrationD(1A) dopamine receptorHomo sapiens (human)
peristalsisD(1A) dopamine receptorHomo sapiens (human)
operant conditioningD(1A) dopamine receptorHomo sapiens (human)
synaptic transmission, glutamatergicD(1A) dopamine receptorHomo sapiens (human)
regulation of dopamine metabolic processD(1A) dopamine receptorHomo sapiens (human)
vasodilationD(1A) dopamine receptorHomo sapiens (human)
dopamine metabolic processD(1A) dopamine receptorHomo sapiens (human)
maternal behaviorD(1A) dopamine receptorHomo sapiens (human)
positive regulation of potassium ion transportD(1A) dopamine receptorHomo sapiens (human)
glucose importD(1A) dopamine receptorHomo sapiens (human)
habituationD(1A) dopamine receptorHomo sapiens (human)
sensitizationD(1A) dopamine receptorHomo sapiens (human)
behavioral response to cocaineD(1A) dopamine receptorHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolD(1A) dopamine receptorHomo sapiens (human)
regulation of dopamine uptake involved in synaptic transmissionD(1A) dopamine receptorHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicD(1A) dopamine receptorHomo sapiens (human)
prepulse inhibitionD(1A) dopamine receptorHomo sapiens (human)
phospholipase C-activating dopamine receptor signaling pathwayD(1A) dopamine receptorHomo sapiens (human)
long-term synaptic potentiationD(1A) dopamine receptorHomo sapiens (human)
long-term synaptic depressionD(1A) dopamine receptorHomo sapiens (human)
cellular response to catecholamine stimulusD(1A) dopamine receptorHomo sapiens (human)
modification of postsynaptic structureD(1A) dopamine receptorHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionD(1A) dopamine receptorHomo sapiens (human)
positive regulation of neuron migrationD(1A) dopamine receptorHomo sapiens (human)
positive regulation of MAPK cascadeD(1A) dopamine receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayD(1A) dopamine receptorHomo sapiens (human)
dopamine receptor signaling pathwayD(1A) dopamine receptorHomo sapiens (human)
temperature homeostasis5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of cytokine production involved in immune response5-hydroxytryptamine receptor 2AHomo sapiens (human)
glycolytic process5-hydroxytryptamine receptor 2AHomo sapiens (human)
intracellular calcium ion homeostasis5-hydroxytryptamine receptor 2AHomo sapiens (human)
activation of phospholipase C activity5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of cytosolic calcium ion concentration5-hydroxytryptamine receptor 2AHomo sapiens (human)
memory5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of cell population proliferation5-hydroxytryptamine receptor 2AHomo sapiens (human)
response to xenobiotic stimulus5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of phosphatidylinositol biosynthetic process5-hydroxytryptamine receptor 2AHomo sapiens (human)
regulation of dopamine secretion5-hydroxytryptamine receptor 2AHomo sapiens (human)
artery smooth muscle contraction5-hydroxytryptamine receptor 2AHomo sapiens (human)
urinary bladder smooth muscle contraction5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of heat generation5-hydroxytryptamine receptor 2AHomo sapiens (human)
negative regulation of potassium ion transport5-hydroxytryptamine receptor 2AHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transduction5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of neuron apoptotic process5-hydroxytryptamine receptor 2AHomo sapiens (human)
protein localization to cytoskeleton5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of fat cell differentiation5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of glycolytic process5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of vasoconstriction5-hydroxytryptamine receptor 2AHomo sapiens (human)
symbiont entry into host cell5-hydroxytryptamine receptor 2AHomo sapiens (human)
sensitization5-hydroxytryptamine receptor 2AHomo sapiens (human)
behavioral response to cocaine5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of inflammatory response5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation5-hydroxytryptamine receptor 2AHomo sapiens (human)
detection of temperature stimulus involved in sensory perception of pain5-hydroxytryptamine receptor 2AHomo sapiens (human)
detection of mechanical stimulus involved in sensory perception of pain5-hydroxytryptamine receptor 2AHomo sapiens (human)
release of sequestered calcium ion into cytosol5-hydroxytryptamine receptor 2AHomo sapiens (human)
negative regulation of synaptic transmission, glutamatergic5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascade5-hydroxytryptamine receptor 2AHomo sapiens (human)
G protein-coupled serotonin receptor signaling pathway5-hydroxytryptamine receptor 2AHomo sapiens (human)
presynaptic modulation of chemical synaptic transmission5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of execution phase of apoptosis5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of platelet aggregation5-hydroxytryptamine receptor 2AHomo sapiens (human)
positive regulation of DNA biosynthetic process5-hydroxytryptamine receptor 2AHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger5-hydroxytryptamine receptor 2AHomo sapiens (human)
phospholipase C-activating serotonin receptor signaling pathway5-hydroxytryptamine receptor 2AHomo sapiens (human)
serotonin receptor signaling pathway5-hydroxytryptamine receptor 2AHomo sapiens (human)
chemical synaptic transmission5-hydroxytryptamine receptor 2AHomo sapiens (human)
response to ethanolD(3) dopamine receptorHomo sapiens (human)
synaptic transmission, dopaminergicD(3) dopamine receptorHomo sapiens (human)
G protein-coupled receptor internalizationD(3) dopamine receptorHomo sapiens (human)
intracellular calcium ion homeostasisD(3) dopamine receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayD(3) dopamine receptorHomo sapiens (human)
adenylate cyclase-activating dopamine receptor signaling pathwayD(3) dopamine receptorHomo sapiens (human)
adenylate cyclase-inhibiting dopamine receptor signaling pathwayD(3) dopamine receptorHomo sapiens (human)
learning or memoryD(3) dopamine receptorHomo sapiens (human)
learningD(3) dopamine receptorHomo sapiens (human)
locomotory behaviorD(3) dopamine receptorHomo sapiens (human)
visual learningD(3) dopamine receptorHomo sapiens (human)
response to xenobiotic stimulusD(3) dopamine receptorHomo sapiens (human)
regulation of dopamine secretionD(3) dopamine receptorHomo sapiens (human)
positive regulation of cytokinesisD(3) dopamine receptorHomo sapiens (human)
circadian regulation of gene expressionD(3) dopamine receptorHomo sapiens (human)
response to histamineD(3) dopamine receptorHomo sapiens (human)
social behaviorD(3) dopamine receptorHomo sapiens (human)
response to cocaineD(3) dopamine receptorHomo sapiens (human)
dopamine metabolic processD(3) dopamine receptorHomo sapiens (human)
response to morphineD(3) dopamine receptorHomo sapiens (human)
negative regulation of blood pressureD(3) dopamine receptorHomo sapiens (human)
positive regulation of mitotic nuclear divisionD(3) dopamine receptorHomo sapiens (human)
acid secretionD(3) dopamine receptorHomo sapiens (human)
behavioral response to cocaineD(3) dopamine receptorHomo sapiens (human)
negative regulation of oligodendrocyte differentiationD(3) dopamine receptorHomo sapiens (human)
arachidonic acid secretionD(3) dopamine receptorHomo sapiens (human)
negative regulation of protein secretionD(3) dopamine receptorHomo sapiens (human)
musculoskeletal movement, spinal reflex actionD(3) dopamine receptorHomo sapiens (human)
regulation of dopamine uptake involved in synaptic transmissionD(3) dopamine receptorHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionD(3) dopamine receptorHomo sapiens (human)
prepulse inhibitionD(3) dopamine receptorHomo sapiens (human)
positive regulation of dopamine receptor signaling pathwayD(3) dopamine receptorHomo sapiens (human)
negative regulation of adenylate cyclase activityD(3) dopamine receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayD(3) dopamine receptorHomo sapiens (human)
negative regulation of voltage-gated calcium channel activityD(3) dopamine receptorHomo sapiens (human)
regulation of potassium ion transportD(3) dopamine receptorHomo sapiens (human)
phospholipase C-activating dopamine receptor signaling pathwayD(3) dopamine receptorHomo sapiens (human)
positive regulation of MAPK cascadeD(3) dopamine receptorHomo sapiens (human)
negative regulation of cytosolic calcium ion concentrationD(3) dopamine receptorHomo sapiens (human)
negative regulation of synaptic transmission, glutamatergicD(3) dopamine receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (29)

Processvia Protein(s)Taxonomy
tyrosine 3-monooxygenase activityTyrosine 3-monooxygenaseHomo sapiens (human)
protein bindingTyrosine 3-monooxygenaseHomo sapiens (human)
ferrous iron bindingTyrosine 3-monooxygenaseHomo sapiens (human)
ferric iron bindingTyrosine 3-monooxygenaseHomo sapiens (human)
amino acid bindingTyrosine 3-monooxygenaseHomo sapiens (human)
oxygen bindingTyrosine 3-monooxygenaseHomo sapiens (human)
enzyme bindingTyrosine 3-monooxygenaseHomo sapiens (human)
protein domain specific bindingTyrosine 3-monooxygenaseHomo sapiens (human)
tetrahydrobiopterin bindingTyrosine 3-monooxygenaseHomo sapiens (human)
dopamine bindingTyrosine 3-monooxygenaseHomo sapiens (human)
G protein-coupled serotonin receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
protein binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
receptor-receptor interaction5-hydroxytryptamine receptor 1AHomo sapiens (human)
neurotransmitter receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
dopamine neurotransmitter receptor activity, coupled via Gi/GoD(2) dopamine receptorHomo sapiens (human)
G-protein alpha-subunit bindingD(2) dopamine receptorHomo sapiens (human)
protein bindingD(2) dopamine receptorHomo sapiens (human)
heterotrimeric G-protein bindingD(2) dopamine receptorHomo sapiens (human)
dopamine bindingD(2) dopamine receptorHomo sapiens (human)
ionotropic glutamate receptor bindingD(2) dopamine receptorHomo sapiens (human)
identical protein bindingD(2) dopamine receptorHomo sapiens (human)
heterocyclic compound bindingD(2) dopamine receptorHomo sapiens (human)
G protein-coupled receptor activityD(2) dopamine receptorHomo sapiens (human)
dopamine neurotransmitter receptor activity, coupled via GsD(1A) dopamine receptorHomo sapiens (human)
G-protein alpha-subunit bindingD(1A) dopamine receptorHomo sapiens (human)
dopamine neurotransmitter receptor activityD(1A) dopamine receptorHomo sapiens (human)
protein bindingD(1A) dopamine receptorHomo sapiens (human)
heterotrimeric G-protein bindingD(1A) dopamine receptorHomo sapiens (human)
dopamine bindingD(1A) dopamine receptorHomo sapiens (human)
arrestin family protein bindingD(1A) dopamine receptorHomo sapiens (human)
G protein-coupled receptor activityD(1A) dopamine receptorHomo sapiens (human)
Gq/11-coupled serotonin receptor activity5-hydroxytryptamine receptor 2AHomo sapiens (human)
virus receptor activity5-hydroxytryptamine receptor 2AHomo sapiens (human)
G protein-coupled serotonin receptor activity5-hydroxytryptamine receptor 2AHomo sapiens (human)
protein binding5-hydroxytryptamine receptor 2AHomo sapiens (human)
protein tyrosine kinase activator activity5-hydroxytryptamine receptor 2AHomo sapiens (human)
identical protein binding5-hydroxytryptamine receptor 2AHomo sapiens (human)
protein-containing complex binding5-hydroxytryptamine receptor 2AHomo sapiens (human)
serotonin binding5-hydroxytryptamine receptor 2AHomo sapiens (human)
1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding5-hydroxytryptamine receptor 2AHomo sapiens (human)
neurotransmitter receptor activity5-hydroxytryptamine receptor 2AHomo sapiens (human)
dopamine neurotransmitter receptor activity, coupled via Gi/GoD(3) dopamine receptorHomo sapiens (human)
protein bindingD(3) dopamine receptorHomo sapiens (human)
G protein-coupled receptor activityD(3) dopamine receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (41)

Processvia Protein(s)Taxonomy
nucleusTyrosine 3-monooxygenaseHomo sapiens (human)
cytoplasmTyrosine 3-monooxygenaseHomo sapiens (human)
mitochondrionTyrosine 3-monooxygenaseHomo sapiens (human)
smooth endoplasmic reticulumTyrosine 3-monooxygenaseHomo sapiens (human)
cytosolTyrosine 3-monooxygenaseHomo sapiens (human)
synaptic vesicleTyrosine 3-monooxygenaseHomo sapiens (human)
cytoplasmic side of plasma membraneTyrosine 3-monooxygenaseHomo sapiens (human)
dendriteTyrosine 3-monooxygenaseHomo sapiens (human)
cytoplasmic vesicleTyrosine 3-monooxygenaseHomo sapiens (human)
melanosome membraneTyrosine 3-monooxygenaseHomo sapiens (human)
neuron projectionTyrosine 3-monooxygenaseHomo sapiens (human)
terminal boutonTyrosine 3-monooxygenaseHomo sapiens (human)
perikaryonTyrosine 3-monooxygenaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosine 3-monooxygenaseHomo sapiens (human)
perikaryonTyrosine 3-monooxygenaseHomo sapiens (human)
cytoplasmTyrosine 3-monooxygenaseHomo sapiens (human)
axonTyrosine 3-monooxygenaseHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
synapse5-hydroxytryptamine receptor 1AHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
dendrite5-hydroxytryptamine receptor 1AHomo sapiens (human)
Golgi membraneD(2) dopamine receptorHomo sapiens (human)
acrosomal vesicleD(2) dopamine receptorHomo sapiens (human)
plasma membraneD(2) dopamine receptorHomo sapiens (human)
ciliumD(2) dopamine receptorHomo sapiens (human)
lateral plasma membraneD(2) dopamine receptorHomo sapiens (human)
endocytic vesicleD(2) dopamine receptorHomo sapiens (human)
axonD(2) dopamine receptorHomo sapiens (human)
dendriteD(2) dopamine receptorHomo sapiens (human)
synaptic vesicle membraneD(2) dopamine receptorHomo sapiens (human)
sperm flagellumD(2) dopamine receptorHomo sapiens (human)
dendritic spineD(2) dopamine receptorHomo sapiens (human)
perikaryonD(2) dopamine receptorHomo sapiens (human)
axon terminusD(2) dopamine receptorHomo sapiens (human)
postsynaptic membraneD(2) dopamine receptorHomo sapiens (human)
ciliary membraneD(2) dopamine receptorHomo sapiens (human)
non-motile ciliumD(2) dopamine receptorHomo sapiens (human)
dopaminergic synapseD(2) dopamine receptorHomo sapiens (human)
GABA-ergic synapseD(2) dopamine receptorHomo sapiens (human)
G protein-coupled receptor complexD(2) dopamine receptorHomo sapiens (human)
glutamatergic synapseD(2) dopamine receptorHomo sapiens (human)
presynaptic membraneD(2) dopamine receptorHomo sapiens (human)
plasma membraneD(2) dopamine receptorHomo sapiens (human)
nucleusD(1A) dopamine receptorHomo sapiens (human)
endoplasmic reticulum membraneD(1A) dopamine receptorHomo sapiens (human)
plasma membraneD(1A) dopamine receptorHomo sapiens (human)
ciliumD(1A) dopamine receptorHomo sapiens (human)
presynaptic membraneD(1A) dopamine receptorHomo sapiens (human)
dendritic spineD(1A) dopamine receptorHomo sapiens (human)
postsynaptic membraneD(1A) dopamine receptorHomo sapiens (human)
ciliary membraneD(1A) dopamine receptorHomo sapiens (human)
non-motile ciliumD(1A) dopamine receptorHomo sapiens (human)
glutamatergic synapseD(1A) dopamine receptorHomo sapiens (human)
GABA-ergic synapseD(1A) dopamine receptorHomo sapiens (human)
G protein-coupled receptor complexD(1A) dopamine receptorHomo sapiens (human)
plasma membraneD(1A) dopamine receptorHomo sapiens (human)
neurofilament5-hydroxytryptamine receptor 2AHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 2AHomo sapiens (human)
caveola5-hydroxytryptamine receptor 2AHomo sapiens (human)
axon5-hydroxytryptamine receptor 2AHomo sapiens (human)
cytoplasmic vesicle5-hydroxytryptamine receptor 2AHomo sapiens (human)
presynaptic membrane5-hydroxytryptamine receptor 2AHomo sapiens (human)
neuronal cell body5-hydroxytryptamine receptor 2AHomo sapiens (human)
dendritic shaft5-hydroxytryptamine receptor 2AHomo sapiens (human)
postsynaptic membrane5-hydroxytryptamine receptor 2AHomo sapiens (human)
cell body fiber5-hydroxytryptamine receptor 2AHomo sapiens (human)
glutamatergic synapse5-hydroxytryptamine receptor 2AHomo sapiens (human)
G protein-coupled serotonin receptor complex5-hydroxytryptamine receptor 2AHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 2AHomo sapiens (human)
dendrite5-hydroxytryptamine receptor 2AHomo sapiens (human)
plasma membraneD(3) dopamine receptorHomo sapiens (human)
synapseD(3) dopamine receptorHomo sapiens (human)
plasma membraneD(3) dopamine receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (55)

Assay IDTitleYearJournalArticle
AID4072In vitro displacement of [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
AID61367Binding affinity against Dopamine receptor D1 from rat brain corpus striatal preparations using [3H]SCH-233901988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID460125Displacement of [3H]8-OH-DPAT from 5HT1A receptor expressed in CHO cells by liquid scintillation counting2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Synthesis of dihydrofuroaporphine derivatives: identification of a potent and selective serotonin 5-HT 1A receptor agonist.
AID313107Inhibition of rat midbrain dopaminergic neuron firing2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Advances in development of dopaminergic aporphinoids.
AID411967Displacement of [3H]nemonapride from dopamine D2 receptor in rat forebrain2009Bioorganic & medicinal chemistry letters, Jan-01, Volume: 19, Issue:1
Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines.
AID170094In vivo accumulation of 5HTP in percent of saline control was determined in cortex of reserpine pretreated rat at dose of 3.2 uM/kg1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
AID317241Displacement of [3H]neomonapride from dopamine D2 receptor in rat striatum2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
AID170106In vivo accumulation of 5HTP in percent of saline control was determined in striatum of reserpine pretreated rat at dose of 3.2 uM/kg1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
AID340034Displacement of [3H]SCH23390 from dopamine D1 receptor in rat corpus striatum2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines.
AID317242Selectivity ratio of rat dopamine D2 receptor to rat dopamine D1 receptor2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
AID231230Potency of compound against D1 receptor to D2 receptor was determined1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID608546Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells at 10 uM after 50 mins by beta liquid scintillation counter2011Journal of medicinal chemistry, Jul-14, Volume: 54, Issue:13
Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.
AID313111Displacement of [3H]SCH-23390 from rat dopamine D1 receptor2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Advances in development of dopaminergic aporphinoids.
AID45983Inhibition of [3H]spiroperidol binding to calf caudate membrane preparation (p4)1981Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
AID569896Displacement of [3H]SCH23390 from dopamine D2 receptor low binding site in Sprague-Dawley rat striatum by scintillation counting2011ACS medicinal chemistry letters, Mar-10, Volume: 2, Issue:3
Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors
AID387701Displacement of [3H]SCH23390 from rat 5HT1A receptor expressed in CHO cells2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands.
AID569898Displacement of [3H]domperidone from human cloned dopamine D3 receptor expressed in mouse CCL1-3 cells by scintillation counting2011ACS medicinal chemistry letters, Mar-10, Volume: 2, Issue:3
Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors
AID460126Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Synthesis of dihydrofuroaporphine derivatives: identification of a potent and selective serotonin 5-HT 1A receptor agonist.
AID387703Displacement of [3H]8OH-DPAT from human dopamine D1 receptor expressed in HEK293 cells2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands.
AID63012Binding affinity against dopamine agonist sites from rat brain corpus striatal preparations using [3H]ADTN1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID34458Dopamine sensitive adenylate cyclase activity (stimulation) in homogenates of rat brain striatal tissue was assessed at 50 uM; + = <40% increase of cAMP above basal activity1981Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
AID411968Selectivity ratio of Ki for dopamine D1 receptor to Ki for dopamine D2 receptor in rat forebrain2009Bioorganic & medicinal chemistry letters, Jan-01, Volume: 19, Issue:1
Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines.
AID64306Displacement of [3H]raclopride from human Dopamine receptor D2A1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
AID64953Binding affinity against Dopamine receptor D2 from rat brain corpus striatal preparations using [3H]spiperone1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID313112Displacement of [3H]raclopride from rat dopamine D2 receptor2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Advances in development of dopaminergic aporphinoids.
AID170100In vivo accumulation of 5HTP in percent of saline control was determined in limbic forebrain of reserpine pretreated rat at dose of 3.2 uM/kg1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
AID340035Displacement of [3H]neomonapride from dopamine D2 receptor in rat corpus striatum2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines.
AID63013Compound was evaluated for its ability to inhibit Striatal Dopamine receptor in rat brain through radioreceptor assay carried out with agonist ligand.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue.
AID168350Stereotyped behavior in rat induced by Aporphines after ip administration at 0.3 mg/kg dose1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID569902Displacement of [3H]domperidone from human cloned dopamine D3 receptor high binding site expressed in mouse CCL1-3 cells by scintillation counting2011ACS medicinal chemistry letters, Mar-10, Volume: 2, Issue:3
Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors
AID608551Displacement of [3H]ketanserin from 5-HT2A receptor expressed in CHO cells at 10 uM after 50 mins by beta liquid scintillation counter2011Journal of medicinal chemistry, Jul-14, Volume: 54, Issue:13
Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.
AID317240Displacement of [3H]SCH-23390 from dopamine D1 receptor in rat striatum2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
AID569897Displacement of [3H]domperidone from dopamine D2 receptor high binding site in Sprague-Dawley rat striatum by scintillation counting2011ACS medicinal chemistry letters, Mar-10, Volume: 2, Issue:3
Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors
AID340037Selectivity ratio of Ki for dopamine D2 receptor to Ki for dopamine D1 receptor in rat corpus striatum2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines.
AID61505Compound was evaluated for its ability to inhibit Dopamine receptor D1 in rat striatum using [3H]SCH-233901991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue.
AID168351Stereotyped behavior in rat induced by Aporphines after ip administration at 0 mg/kg dose1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID170341Effect (3 mg/kg) on motor arousal induced by apomorphine1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID173457Effect (3 mg/kg) on motor arousal induced by apomorphine (0.3 mg/kg) expressed as percent control1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID387702Displacement of [3H]Spiperone from human 5HT2A receptor expressed in HEK293 cells2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands.
AID569900Binding affinity to dopamine D1 receptor high binding site by radioligand displacement assay2011ACS medicinal chemistry letters, Mar-10, Volume: 2, Issue:3
Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors
AID170254In vivo accumulation of DOPA in percent of saline control was determined in striatum of reserpine pretreated rat at dose of 3.2 uM/kg1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
AID569899Binding affinity to dopamine D1 receptor low binding site by radioligand displacement assay2011ACS medicinal chemistry letters, Mar-10, Volume: 2, Issue:3
Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors
AID387704Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands.
AID168353Stereotyped behavior in rat induced by Aporphines after ip administration at 3.0 mg/kg dose1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID170112In vivo accumulation of DOPA in percent of saline control was determined in cortex of reserpine pretreated rat at dose of 3.2 uM/kg1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
AID65276Compound was evaluated for its ability to inhibit Dopamine receptor D2 in rat striatum using [3H]spiperone1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue.
AID460127Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Synthesis of dihydrofuroaporphine derivatives: identification of a potent and selective serotonin 5-HT 1A receptor agonist.
AID313108Inhibition of tyrosine hydroxylase2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Advances in development of dopaminergic aporphinoids.
AID226743Potency ratio calculated from the ratio of D2 to that of D1 receptors1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue.
AID411966Displacement of [3H]SCH23390 from dopamine D1 receptor in rat forebrain2009Bioorganic & medicinal chemistry letters, Jan-01, Volume: 19, Issue:1
Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines.
AID168352Stereotyped behavior in rat induced by Aporphines after ip administration at 1.0 mg/kg dose1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
AID170248In vivo accumulation of DOPA in percent of saline control was determined in limbic forebrain of reserpine pretreated rat at dose of 3.2 uM/kg1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
AID45982Inhibition of [3H]apomorphine binding to calf caudate membrane preparation (p4)1981Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
AID313114Displacement of [3H]8-OH-DPAT from rat 5HT1A receptor2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Advances in development of dopaminergic aporphinoids.
AID61514In vitro displacement of [3H]SCH-23390 binding to rat striatal Dopamine receptor D11996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (16.67)18.7374
1990's2 (16.67)18.2507
2000's5 (41.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.10 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]